Thelansis

Introduction: In today’s dynamic pharmaceutical landscape, the need for seamless data access and faster decision-making has made AI-powered, cloud-based solutions a cornerstone of innovation. As a pharma company that works across multiple therapy areas simultaneously, traditional data silos have proven inefficient for providing insights into country-specific disease burden, epidemiology research, and, essentially, market forecasts. To address these challenges, Thelansis developed an AI-enabled cloud platform that transforms how organizations access, analyze, and apply epidemiology and market insights. This case study explores how Thelansis partnered with a global biopharma client to streamline their research processes. Objective: A client with a diverse product portfolio sought a centralized, scalable, and Competitive Intelligence system to access reliable epidemiology and disease landscape insights. Our team collaborated with theirs to understand their requirements, based on the...

Introduction: In today’s competitive pharmaceutical industry, success relies on anticipating market changes. With rapidly growing data sources, AI-powered data analytics solutions, and predictive modeling, organizations are commanded to stay ahead of the competition. The Challenge: Pharma companies rely heavily on retrospective market research — analyzing sales trends, competitor moves, and therapeutic launches as they feel required. Delay in the decision-making process and missed opportunities. In an era where even a few months’ head start can define market dominance, Pharma leaders need real-time insights into: Emerging competitor strategies Shifting prescriber preference Patient-centric unmet needs Regulatory scenarios Sales trajectory inflections The Shift: From Retrospective to Prospective By using AI-enabled predictive analytics, teams can analyze market signals — such as pipeline progress, clinical trial outcomes, physician sentiment, KOL perspectives, and...